Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
about
A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in MiceFactors contributing to the immunogenicity of meningococcal conjugate vaccinesFrom Immunologically Archaic to Neoteric Glycovaccines.Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.The Effect of Physicochemical Modification on the Function of Antibodies Induced by Anti-Nicotine Vaccine in Mice.Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping.Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersChemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sitesStructure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide.CD301b+ dendritic cells suppress T follicular helper cells and antibody responses to protein antigens.Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.Co-expression of sulphydryl oxidase and protein disulphide isomerase in Escherichia coli allows for production of soluble CRM197.Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo.Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial.Modulation of interaction of mutant TP53 and wild type BRCA1 by alkaloids: a computational approach towards targeting protein-protein interaction as a futuristic therapeutic intervention strategy for breast cancer impediment.Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.High-yield production of recombinant CRM197, a non-toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli.Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coliStructural and immunological characterization of derived recombinant CRM protein used as carrier in conjugate vaccines
P2860
Q28554288-0B145AA4-7EA0-4B73-834A-F24745C13594Q28828544-758C74AE-AF75-453E-BFDD-2192308E051EQ30238724-6E1D426E-ED94-4E78-ACC6-20CDFD500986Q30388683-707933AD-D2CD-4750-99FF-1D1B0888CA5FQ33855905-2A71BCFB-1C5A-4366-9CD8-E1CCAEFC1BFCQ35116917-CDCCBA8C-B60E-413B-9DB5-BC272FF02D6EQ35548057-84828E59-374F-4B91-8E10-21DF9D68847BQ35756201-20D8E9ED-60F0-41F0-820D-C2D032BEE13CQ35783024-27FFE70A-BFF1-4E7C-96EF-712746627BABQ35913681-80050ECB-C10F-4FDC-9F00-56236DB474D0Q36147897-E9CF154F-5C33-4ADB-B9BB-238F08BDE162Q36276014-EF425AA5-00E8-4E2A-89B7-34569EC975D8Q37276771-7A0EF07E-6D07-4ADC-AE55-284ACFA9B0D6Q37352073-D7ECA36B-00C9-4D9B-A7DF-40D5373F250DQ38958467-464454BC-3FE6-427C-AAA7-90CB85F70010Q39093233-1438A39C-B6A8-4048-BAB4-8E644B440EDEQ46027898-A375EFAA-E657-46BD-AF03-B18DE0356924Q46911551-0D8C4A85-4074-4B09-BC11-7573FAD932E7Q47119242-AC81B427-26DB-4195-BFEC-70FBFD36399CQ47154849-DBAAD6A3-D00D-4447-942F-504FC2C3C60BQ47697811-4D5D9F38-E236-4D1E-8ADA-1F43534A5984Q48096971-E1052DB7-B4CC-471A-ABFF-78DD26CC5436Q51063827-2342B69D-A5EB-4DAA-B63C-A656FD91ABA7Q58358482-8411E339-5955-46F7-877F-DE7376E87D27Q58699527-B6AD75D3-212D-44F4-B6A2-4626432FB4FE
P2860
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@ast
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@en
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@nl
type
label
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@ast
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@en
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@nl
prefLabel
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@ast
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@en
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@nl
P2093
P2860
P3181
P356
P1476
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
@en
P2093
Ansgar Brock
Badry Bursulaya
Connie Chen
Enrico Balducci
Enrico Malito
Francesco Berti
Marco Biancucci
Matthew James Bottomley
Mikkel Nissum
Monica Picchianti
P2860
P304
P3181
P356
10.1073/PNAS.1201964109
P407
P577
2012-04-03T00:00:00Z